B

BMY

Bristol-Myers Squibb Company
HealthcareDrug Manufacturers - General|New York Stock Exchange|US

Price

$59.60

Market Cap

$121.37B

Beta

0.27

P/E

16.7

Div Yield

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)-0.22%
EPS Growth (YoY)+177.97%
Revenue CAGR 3Y+1.45%
P/E Ratio16.7
PEG Ratio0.10
FCF Yield+10.58%
Debt / Equity2.55
Interest Coverage8.4x

Sign up free to unlock full analysis

  • Full 24-factor quality scorecard
  • AI investment committee analysis
  • Factor radar & value trap detection
  • 10-year strategy backtesting
  • Advanced screening & filtering
Get started free

No credit card required

Already have an account? Sign in to view the full analysis for BMY.

BMY — Bristol-Myers Squibb Company Stock Analysis | Tessera Alpha